ViaCyte raises $80 million for diabetes therapy - The San Diego Union-Tribune

The San Diego Union-Tribune

ViaCyte raises $80 million for diabetes therapy The San Diego Union-Tribune Diabetes therapy developer ViaCyte has raised $80 million, its largest financing to date, the San Diego biomedical company said Wednesday. ViaCyte will use the money to advance its stem cell-derived therapies, said Paul Laikind, president and CEO of ... and more »

from diabetes - Google News